Sichenzia Ross Ference Kesner LLP代表A.G.P / Alliance Global Partners（通过Euro Pacific Capital）以600万美元公开发行Cocrystal Pharma，Inc.的普通股。
Press Release – New York, NY – May 3rd, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented A.G.P/ Alliance Global Partners (through Euro Pacific Capital) as sole book running manager in the underwritten public offering of shares of Common Stock of Cocrystal Pharma, Inc. (NASDAQ: COCP). Cocrystal sold an aggregate of 4,210,527 shares of Common Stock at a price of $1.90 per share. Cocrystal is a clinical stage biotechnology company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Sichenzia Ross Ference Kesner LLP team was led by partners Marc Ross, Avital Perlman and Tom Rose.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- 创始合伙人Gregory Sichenzia专注于商业内幕人士讨论Elon Musk的推文和证券合法性 - August 8, 2018
- Anthony Ciaccio - July 6, 2018
- Sichenzia Ross Ference Kesner LLP以4.75美元的债务交易代表New Age Beverages Corporation - June 26, 2018